CAS 1567915-38-1

Formula: C26H30N6O3

InChI: InChI=1S/C26H30N6O3/c1-16-13-34-11-10-31(16)26-29-23-21(24(30-26)32-19-6-7-20(32)15-35-14-19)8-9-22(28-23)17-4-3-5-18(12-17)25(33)27-2/h3-5,8-9,12,16,19-20H,6-7,10-11,13-15H2,1-2H3,(H,27,33)/t16-,19?,20?/m0/s1

InChI key: LVPBYQVQBZLDAU-DZIBYMRMSA-N

SMILES: C[C@H]1COCCN1C2=NC3=C(C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)C(=N2)N5C6CCC5COC6

MTI-31

CAS: 1567915-38-1

MTI-31

Formula: C₂₆H₃₀N₆O₃

Purity: ≥98%

Molecular weight: 474.55

Ref: 54-BUP00516

MTI-31

CAS: 1567915-38-1

Ref: IN-DA023RLI

MTI-31

CAS: 1567915-38-1

MTI-31 is a synthetic, orally bioavailable small molecule that binds to the regulatory domain of the GRP78 protein. MTI-31 has been shown to have antiproliferative effects in vitro and in vivo by inhibiting the activity of the protein synthesis machinery. It also suppresses tumor growth and induces an antitumor response. MTI-31 interacts with pd-l1, a receptor for phosphatidylserine, which has been implicated in cancer cell proliferation and apoptosis. The kinase domain of MTI-31 inhibits tumor growth by preventing cellular proliferation and inducing apoptosis.

Formula: C₂₆H₃₀N₆O₃

Purity: Min. 95%

Molecular weight: 474.6 g/mol

Ref: 3D-SMC91538

MTI-31

CAS: 1567915-38-1

MTI-31 (LXI-15029) is a potent oral mTORC1/2 inhibitor with a Kd of 0.20 nM, >5,000-fold selectivity, and an IC50 of 39 nM.

Formula: C₂₆H₃₀N₆O₃

Purity: 99.97%

Color and Shape: Yellow Solid

Molecular weight: 474.5548

Ref: TM-T35343